Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Antibodies, Bispecific × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 4 Lymphoid 3 Other hematologic neoplasm 2 Thoracic 1 Plasma cell 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1

Conditions

Thyroid Neoplasms 1

Interventions

Cisplatin 550 Radiotherapy 298 pembrolizumab 289 Cetuximab 244 Docetaxel 200 Radiotherapy, Intensity-Modulated 197 Fluorouracil 177 Carboplatin 174 Paclitaxel 148 Nivolumab 127 Gemcitabine 113 Radiation 82 Magnetic Resonance Spectroscopy 81 Drug Therapy 75 toripalimab 68 Capecitabine 67 Surveys and Questionnaires 64 Surgical Procedures, Operative 62 Biopsy 58 durvalumab 55 Blood Specimen Collection 48 Cyclophosphamide 43 Chemoradiotherapy 43 camrelizumab 41 Standard of Care 39 Specimen Handling 39 Erlotinib Hydrochloride 38 Bevacizumab 38 tislelizumab 37 Radiosurgery 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00467506 2011-11-11

RIT in MTC

Nantes University Hospital

Phase 2 Completed

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡